Bone cancer

Clinical Practice Guidelines in Oncology™

J. Sybil Biermann, Douglas Adkins, Robert Benjamin, Brian Brigman, Warren Chow, Ernest U. Conrad, Deborah Frassica, Frank J. Frassica, Suzanne George, John H. Healey, Robert Heck, G. Douglas Letson, Joel Mayerson, Sean V. McGarry, Richard J. O'Donnell, Joshua Patt, R. Lor Randall, Victor Santana, Robert L. Satcher, Richard G. Schmidt & 3 others Herrick J. Siegel, Michael K. Wong, Alan W. Yasko

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Primary bone cancers are extremely rare neoplasms, accounting for less than 0.2% of all cancers. Primary bone cancers show wide clinical heterogeneity and, perhaps most importantly, are often curable. With current multimodality treatment, including multi-agent chemotherapy, approximately three quarters of all patients diagnosed with osteosarcoma are cured. Updates for 2007 include changes in recommendations for treating chondrosarcoma, Ewing's sarcoma, and osteosarcoma.

Original languageEnglish (US)
Pages (from-to)420-437
Number of pages18
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number4
StatePublished - Apr 1 2007

Fingerprint

Bone Neoplasms
Osteosarcoma
Practice Guidelines
Chondrosarcoma
Ewing's Sarcoma
Neoplasms
Drug Therapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Biermann, J. S., Adkins, D., Benjamin, R., Brigman, B., Chow, W., Conrad, E. U., ... Yasko, A. W. (2007). Bone cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 5(4), 420-437.

Bone cancer : Clinical Practice Guidelines in Oncology™. / Biermann, J. Sybil; Adkins, Douglas; Benjamin, Robert; Brigman, Brian; Chow, Warren; Conrad, Ernest U.; Frassica, Deborah; Frassica, Frank J.; George, Suzanne; Healey, John H.; Heck, Robert; Letson, G. Douglas; Mayerson, Joel; McGarry, Sean V.; O'Donnell, Richard J.; Patt, Joshua; Randall, R. Lor; Santana, Victor; Satcher, Robert L.; Schmidt, Richard G.; Siegel, Herrick J.; Wong, Michael K.; Yasko, Alan W.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 4, 01.04.2007, p. 420-437.

Research output: Contribution to journalArticle

Biermann, JS, Adkins, D, Benjamin, R, Brigman, B, Chow, W, Conrad, EU, Frassica, D, Frassica, FJ, George, S, Healey, JH, Heck, R, Letson, GD, Mayerson, J, McGarry, SV, O'Donnell, RJ, Patt, J, Randall, RL, Santana, V, Satcher, RL, Schmidt, RG, Siegel, HJ, Wong, MK & Yasko, AW 2007, 'Bone cancer: Clinical Practice Guidelines in Oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 4, pp. 420-437.
Biermann JS, Adkins D, Benjamin R, Brigman B, Chow W, Conrad EU et al. Bone cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2007 Apr 1;5(4):420-437.
Biermann, J. Sybil ; Adkins, Douglas ; Benjamin, Robert ; Brigman, Brian ; Chow, Warren ; Conrad, Ernest U. ; Frassica, Deborah ; Frassica, Frank J. ; George, Suzanne ; Healey, John H. ; Heck, Robert ; Letson, G. Douglas ; Mayerson, Joel ; McGarry, Sean V. ; O'Donnell, Richard J. ; Patt, Joshua ; Randall, R. Lor ; Santana, Victor ; Satcher, Robert L. ; Schmidt, Richard G. ; Siegel, Herrick J. ; Wong, Michael K. ; Yasko, Alan W. / Bone cancer : Clinical Practice Guidelines in Oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 4. pp. 420-437.
@article{1904f00c76cd464083966967cd852d53,
title = "Bone cancer: Clinical Practice Guidelines in Oncology™",
abstract = "Primary bone cancers are extremely rare neoplasms, accounting for less than 0.2{\%} of all cancers. Primary bone cancers show wide clinical heterogeneity and, perhaps most importantly, are often curable. With current multimodality treatment, including multi-agent chemotherapy, approximately three quarters of all patients diagnosed with osteosarcoma are cured. Updates for 2007 include changes in recommendations for treating chondrosarcoma, Ewing's sarcoma, and osteosarcoma.",
author = "Biermann, {J. Sybil} and Douglas Adkins and Robert Benjamin and Brian Brigman and Warren Chow and Conrad, {Ernest U.} and Deborah Frassica and Frassica, {Frank J.} and Suzanne George and Healey, {John H.} and Robert Heck and Letson, {G. Douglas} and Joel Mayerson and McGarry, {Sean V.} and O'Donnell, {Richard J.} and Joshua Patt and Randall, {R. Lor} and Victor Santana and Satcher, {Robert L.} and Schmidt, {Richard G.} and Siegel, {Herrick J.} and Wong, {Michael K.} and Yasko, {Alan W.}",
year = "2007",
month = "4",
day = "1",
language = "English (US)",
volume = "5",
pages = "420--437",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - Bone cancer

T2 - Clinical Practice Guidelines in Oncology™

AU - Biermann, J. Sybil

AU - Adkins, Douglas

AU - Benjamin, Robert

AU - Brigman, Brian

AU - Chow, Warren

AU - Conrad, Ernest U.

AU - Frassica, Deborah

AU - Frassica, Frank J.

AU - George, Suzanne

AU - Healey, John H.

AU - Heck, Robert

AU - Letson, G. Douglas

AU - Mayerson, Joel

AU - McGarry, Sean V.

AU - O'Donnell, Richard J.

AU - Patt, Joshua

AU - Randall, R. Lor

AU - Santana, Victor

AU - Satcher, Robert L.

AU - Schmidt, Richard G.

AU - Siegel, Herrick J.

AU - Wong, Michael K.

AU - Yasko, Alan W.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Primary bone cancers are extremely rare neoplasms, accounting for less than 0.2% of all cancers. Primary bone cancers show wide clinical heterogeneity and, perhaps most importantly, are often curable. With current multimodality treatment, including multi-agent chemotherapy, approximately three quarters of all patients diagnosed with osteosarcoma are cured. Updates for 2007 include changes in recommendations for treating chondrosarcoma, Ewing's sarcoma, and osteosarcoma.

AB - Primary bone cancers are extremely rare neoplasms, accounting for less than 0.2% of all cancers. Primary bone cancers show wide clinical heterogeneity and, perhaps most importantly, are often curable. With current multimodality treatment, including multi-agent chemotherapy, approximately three quarters of all patients diagnosed with osteosarcoma are cured. Updates for 2007 include changes in recommendations for treating chondrosarcoma, Ewing's sarcoma, and osteosarcoma.

UR - http://www.scopus.com/inward/record.url?scp=34248216469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248216469&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 420

EP - 437

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -